All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety, as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference in its entirety.
This invention relates generally to the imaging field, and more specifically to a new and useful system and method for real-time tracking of a target tissue using imaging before and during therapy delivery.
Therapeutic energy delivery from a distance involves transmission of energy waves to affect a target tissue inside a patient's body. Therapeutic delivery of ultrasound waves has been used in a wide variety of therapeutic interventions, including lithotripsy, drug delivery, cancer therapy, thrombolysis, and tissue ablation. Non-invasive delivery of focused energy may allow for more efficient delivery of energy to the target tissue, improved cost effectiveness of treatment, minimized trauma to the patient's body, and improved recovery time.
Delivering energy over a distance requires targeting accuracy and technological flexibility while minimizing invasiveness into the patient. However, current methods fail to adequately track the target tissue motion while concurrently delivering the energy or therapy. A tissue in the body moves relative to the energy-delivering source from either the unintended patient body motion or the internal organs' motion due to heartbeat, breathing, blood flow, or other physiological functions. Current methods stop delivering the energy or therapy when the tissue moves out of focus or visibility due, at least, to breathing or shadows and reinitiates energy or therapy delivery when the tissue reemerges. The stopping and starting of therapy or energy delivery can have unintended consequences for the patient, such as variable dosing, uneven or insufficient therapy delivery to the target tissue, and prolonged procedure times.
Conventional ultrasound systems for tracking a targeted soft tissue motion have a much lower signal-to-noise ratio. Further, the shape of a target image can change more as it moves within the image because of ultrasound beam scan orientation, tissue deformation, ultrasound signal distortion and other factors. Controlling these factors is desirable for effective and accurate therapeutic energy delivering to the target tissue. Since soft tissue deforms at a macroscopic level, conventional tracking systems cannot adequately track such tissue deformation and motion. Further, tracking and energy delivery will halt when a conventional system loses the target tissue, due to, for example, rib shadows or deep breaths that move the target out of sight. This happens regularly in conventional systems. Conventional systems are not configured to deal with these motions, and even more importantly they are not configured to properly recover tracking once the image reappears, requiring user input to relocate the lost target tissue in the image.
Thus, there is a need for a new and useful system and method for tracking a target tissue using imaging before and during therapy delivery. In particular, there is a need for new and useful systems and methods configured to accommodate when tissue moves out of focus or visibility, and even more importantly configured to automatically recover tracking when the image reappears. This invention provides such a new and useful system and method.
A system for identifying at least one anatomical structure and tracking a motion of the at least one anatomical structure using imaging before and during delivery of a therapy to a patient, includes: an imaging module configured to identify a location and a feature of a region of the anatomical structure in an image, wherein the imaging module comprises a tracker, a detector, and an integrator; and a therapy module comprising an ultrasound treatment transducer configured to deliver the therapy to a target tissue in the patient.
Optionally, the imaging module is configured to, in real-time, track the anatomical structure using a feature identification technique.
Optionally, the imaging module is configured to use a histogram of the anatomical structure in the image, or a feature matching technique.
Optionally, the imaging module is configured to identify a location of the target tissue to be treated by the therapy module.
Optionally, the tracker is configured to identify a new location or a new feature of the region of the anatomical structure in response to a change in the location and the feature of the region of the anatomical structure.
Optionally, the detector is configured to identify a shape, a location, and a feature of the region of the anatomical structure.
Optionally, the tracker, detector, and integrator are implemented in graphics processor unit (GPU), field-programmable gate array (FPGA) or digital signal processor (DSP) or any other units containing computation capabilities.
Optionally, the therapy module is configured to function concurrently with the imaging module.
Optionally, the therapy module is configured to deliver therapy to the target tissue despite a change in the location or the feature of the region of the anatomical structure.
Optionally, the anatomical structure comprises the target tissue.
Optionally, at least one of breathing, blood flow, conscious movement, or unconscious movement of the patient changes the location and/or the feature of the region of the anatomical structure.
Optionally, the imaging module is configured to identify the location and the feature of the region of the anatomical structure in less than 1 second.
Optionally, the imaging module is configured to identify the location and the feature of the region of the anatomical structure in less than 5 milliseconds.
Optionally, the target tissue comprises a renal artery.
Optionally, the ultrasound treatment transducer is configured to provide renal denervation.
Optionally, the imaging module is configured to track the region of the anatomical structure is using a B-mode image, Harmonic Imaging, or 3D ultrasound imaging.
Optionally, the imaging module is configured to track the region of the anatomical structure using a color Doppler image, a color power Doppler image, or a directional color power Doppler mode image.
Optionally, the system further includes a filter, wherein the filter is configured to reduce noise in the image, such that the imaging module can determine the location and the feature of the region of the anatomical structure in the image.
Optionally, the filter is configured to provide a filtered image that is visible to the tracker, the detector, or both the tracker and detector.
Optionally, the system further includes a user interface for allowing a user to choose between viewing the filtered image or an unfiltered image.
Optionally, the location is an x and y coordinate.
Optionally, the location is an x, y, and z coordinate.
Optionally, the image is an ultrasound image.
Optionally, the integrator is configured to integrate results from the tracker and detector and direct the therapy module to deliver the therapy to the target tissue.
Optionally, the location is in a plane.
Optionally, the location is in a three-dimensional space.
Optionally, a plane of movement of the anatomical structure is substantially parallel to an imaging plane of the imaging module.
Optionally, the feature includes one or more of a characteristic, intensity, density, contrast, and shape of the region of the anatomical structure.
Optionally, the imaging module and the therapy module are configured to function consecutively using an interleaving mechanism.
Optionally, the imaging module and the therapy module are configured to function concurrently using a continuous mechanism.
Optionally, the therapy module is configured to predict a future location or a future feature of the target tissue and to deliver the therapy to the target tissue when the target tissue reaches the future location or the future feature.
Optionally, the therapy module is configured to provide lithotripsy.
Optionally, the lithotripsy comprises treatment of a kidney stone, gallstone, bile duct stone, or ureter stone.
Optionally, the tracker comprises a short-term detector.
Optionally, the detector comprises a long-term detector.
A system for tracking a renal artery during delivery of an ultrasound therapy to a patient, includes: an imaging module configured to identify a location and a feature of a region of an anatomical structure in an ultrasound image, wherein the imaging module comprises a tracker, a detector, and an integrator; and a therapy module comprising an ultrasound treatment transducer configured to deliver the ultrasound therapy to the renal artery, wherein the ultrasound treatment transducer is configured to be mechanically moved and/or electronically controlled.
Optionally, the ultrasound treatment transducer is configured to be moved by a motion control mechanism to move the ultrasound treatment transducer.
Optionally, the ultrasound treatment transducer comprises a full circular annular phased array.
Optionally, the ultrasound treatment transducer comprises a partial circular annular phased array.
Optionally, the ultrasound treatment transducer is configured to be directed and moved to guide therapeutic energy to the renal artery.
Optionally, the ultrasound treatment transducer comprises a two-dimensional array and is configured to move therapy focus by a three-dimensional electronic control mechanism to guide therapeutic energy to the renal artery.
Optionally, the ultrasound treatment transducer is configured to be moved by a mechanical control mechanism to guide therapeutic energy to the renal artery.
A method for imaging during delivery of a therapy, includes: acquiring an image of a body portion of a patient; identifying a region of an anatomical structure that has a relationship to a target tissue in the image; tracking a location and/or a feature of the region of the anatomical structure in the image; integrating results from the act of tracking; generating a template library to cover possible changes of the location and/or changes of the feature of the region of the anatomical structure; and delivering the therapy to the target tissue while tracking the region of the anatomical structure in the image.
Optionally, the method further includes continuously delivering therapy to the target tissue despite a change in one or more locations and features of the region of the anatomical structure.
Optionally, the act of tracking occurs in response to a change in the location or the feature of the region of the anatomical structure.
Optionally, the region of the anatomical structure comprises the target tissue.
Optionally, at least one of breathing, blood flow, conscious movement, or unconscious movement of the patient changes the location and/or the feature of the region of the anatomical structure.
Optionally, the region of the anatomical structure is undetectable by the imaging module as a result of at least one of breathing, blood flow, conscious movement, and unconscious movement.
Optionally, the method further includes stopping imaging of the body portion of the patient when the region of the anatomical structure is undetectable.
Optionally, the method further includes automatically re-detecting the region of the anatomical structure location or feature.
Optionally, the automatically recovering step further comprises automatically recovering the region of the anatomical structure location or feature by first determining a last known location or feature of the region of the anatomical structure in the image.
Optionally, the act of tracking occurs in less than 5 milliseconds.
Optionally, the act of delivering the therapy comprises denervating renal nerves surrounding the renal artery.
Optionally, the act of delivering comprises delivering ultrasound to the target tissue.
Optionally, the act of tracking comprises using a B-mode image, Harmonic Imaging, or 3D ultrasound imaging.
Optionally, the act of tracking comprises using a color Doppler image, a color power Doppler image, or a directional color power Doppler mode image.
Optionally, the act of tracking comprises using an image in B-mode, Harmonic mode, color Doppler mode, color power Doppler mode, a combination of the B-mode, the Harmonic mode and the color Doppler mode.
Optionally, the method further includes filtering the image to obtain a filtered image, such that the anatomical structure can be tracked in the filtered image.
Optionally, the method further includes determining if a pre-existing template matches a result from the act of tracking.
Optionally, the method further includes determining if a result from the act of tracking should be updated as a new template.
Optionally, a position of the target tissue is based on the pre-existing template and a new template. For example, averaging (e.g., weighted averaging, non-weighted averaging) may be performed using information in the pre-existing template and the new template to determine the position of the target tissue.
Optionally, the method further includes generating a new template when a pre-existing template does not match a result from the act of tracking, wherein the new template defines or indicates a location and a shape of the target tissue.
A method for treatment includes: acquiring with an imaging module an image of a body portion of a patient; identifying a region of an anatomical structure that has a relationship to a target tissue in the image; tracking a location and/or a feature of the region of the anatomical structure in the image; transforming a target position of the target tissue from an imaging space associated with the imaging module to a treatment space associated with a therapy module through one or more position sensors and a transmitter; and delivering a therapy with the therapy module to the target tissue while tracking the region of the anatomical structure.
Optionally, the one or more position sensors and the transmitter are configured to link a position of an imaging transducer of the imaging module to a position of an ultrasound treatment transducer of the therapy module.
Optionally, the one or more position sensors comprises a magnetic sensor, an optical sensor, an ultrasound sensor, or a mechanical position sensor.
Optionally, the one or more position sensors are mounted on an imaging transducer of the imaging module.
Optionally, the transmitter is mounted on an imaging transducer of the imaging module.
Optionally, the one or more position sensors are mounted on an ultrasound treatment transducer of the therapy module.
Optionally, the transmitter is mounted on an ultrasound treatment transducer of the therapy module.
The following description of the preferred embodiments of the invention is not intended to limit the invention to these preferred embodiments, but rather to enable any person skilled in the art to make and use this invention. Disclosed herein are systems and methods for identifying at least one anatomical structure and tracking the motion of the at least one anatomical structure using imaging before and during delivery of a therapy to a patient.
Described herein are systems and methods for tracking an anatomical structure in a patient and delivering therapy to an anatomical structure. The structure receiving the delivered therapy from the system is the target tissue. In some embodiments, the system may function completely non-invasively. Alternatively, the system may additionally include catheterization or otherwise surgically manipulating the patient. The system may be used to track an anatomical structure, such as an organ, blood vessel, artery, bone, blood, or any other type of anatomical structure. For example, in some embodiments, the system may function to track a kidney or renal artery of a patient. Alternatively, the system may be used to track a region of an anatomical structure, such as a curved edge or surface, a more distal or proximal portion of an organ, blood flow through a vessel, a distinguishing feature of an organ, for example glomeruli of the kidney, or any other region of interest of an anatomical structure. In some embodiments, a feature of an anatomical structure may be tracked, such as a location, shape, intensity, contrast, density, or otherwise characteristic of the anatomical structure. The location of an anatomical structure may include an x, y coordinate or an x, y, z coordinate. Alternatively, the location of the anatomical structure may be tracked in a two-dimensional plane or in three-dimensional space. The tracked anatomical structure may be a different structure than the anatomical structure receiving therapy from the system, such that a change in location or feature of the anatomical structure indicates a change in position of the target tissue. Alternatively, the anatomical structure may be the same as the target tissue, such that the target tissue is the anatomical structure that is being tracked. In some embodiments, the tracked anatomical structure may be a kidney and the target tissue receiving therapy may be a renal artery.
In some embodiments, the system may deliver therapy via ultrasound, mechanical vibrations, electromagnetic waves, lasers, X-ray or any other type of non-invasive radiation therapy. The therapy may include renal denervation, kidney stone disruption, gallstone disruption, bile duct stone disruption, ureter stone disruption, or any other type of non-invasive therapy.
In general, an anatomical structure may be lost and/or move during tracking and/or while receiving therapy. For example, an anatomical structure may be lost due to a shadow from another organ or bone structure, for example the rib cage. Alternatively or additionally, an anatomical structure may move due to breathing, blood flow, conscious movement, or unconscious movement of the patient during the procedure. In some instances, the region of the anatomical structure may become undetectable by the system as a result of breathing, blood flow, conscious movement, or unconscious movement of the patient. For example, an anatomical structure may move approximately 2 cm/second. In some instances, the anatomical structure may move substantially in a plane parallel to the plane of the system, or principal plane. Alternatively, the anatomical structure may move perpendicularly or variably relative to the system. As described herein, the system is configured to track a region of an anatomical structure despite shadows or deep breathing by a patient that moves an anatomical structure out of sight.
In some embodiments, the system may utilize an imaging module to locate the target tissue and track the position and/or movements of the target tissue, such that the therapy module can maintain its focus on the target tissue during the treatment process. In some embodiments, the imaging information may be used to confirm that the focus of the therapy module is properly positioned over the treatment region. The system then calculates the treatment parameter, such as dosing of ultrasound energy to be applied to the treatment region. For example the physician may enter the desired dosing level for a particular treatment. The system may also take into account other parameters, such as the distance of the target region from the therapy module, and calculate the appropriate ultrasound energy to apply to achieve the desired dosing at the target region. A particular treatment plan, such as a specific treatment pattern (e.g., energizing multiple spots within a treatment area), and a specific dosing routine (e.g., spreading a dose into multiple quantized delivery over a finite period of time to achieve the desired dose) may be selected. The system may then implement the treatment plan, and ultrasound energy may be delivered to the treatment region based on the treatment plan. In some embodiments, the treatment plan includes sequential lesions offset from the blood flow of a vessel and within 5 mm of one another. In another embodiment, the treatment plan includes sequential lesions offset from the blood flow and within 1 mm of each other. In another embodiment, the sequential lesions do not have an offset from one another and sequential lesions are applied atop one another in substantially the same position.
In some embodiments, the therapy module 102 may include a therapy energy delivering subsystem 107, which functions to generate controlled electrical energy to the ultrasound treatment transducer 108. In some embodiments, the ultrasound treatment transducer 108 transmits the ultrasound energy into the targeted tissue structure in a human body. In some embodiments, the ultrasound treatment transducer 108 may be a full circular annular phased array transmitting the focused ultrasound energy along the acoustic axis in depth direction into the targeted tissue structure in a human body. In other embodiments, the ultrasound treatment transducer 108 may be a section of full (e.g., partial) circular annular phased array transmitting the focused ultrasound energy along the acoustic axis in depth direction into the targeted tissue structure in a human body. For example, the transducer may have a pie shape so that the shape is less than a full circular shape. In some embodiments, the therapy module 102 may include a tip/tilt motion control unit 109 that adjusts the ultrasound treatment transducer rotation in tip and tilt directions to follow the targeted tissue motion. In other embodiments, the following of the targeted tissue motion may be accomplished by electronic control of the phasing of the ultrasound elements in the ultrasound treatment transducer, thereby obviating the need to mechanically move the ultrasound treatment transducer. In further embodiments, the control of the ultrasound energy focus may be accomplished using both electronic phasing control of ultrasound elements in the ultrasound transducer 108 and mechanical control of the movement of the ultrasound transducer 108 by the therapy module 102. In some cases, such technique may allow control of ultrasound energy focus at any position within a huge treatment volume in 3D space. In some embodiments, the therapy module 102 may further include a transmitter and/or one or more position sensors of a 3D position system 110.
In some embodiments, the imaging module 101 may include an image acquisition subsystem 103 that functions to acquire an image. In some embodiments, the image acquisition subsystem 103 may use ultrasound to acquire images of a region of an anatomical structure. In some embodiments, the imaging module 101 may further include an image tracking system 104 that functions to track a location and/or feature of an anatomical structure within the image acquired by the image acquisition subsystem 103. In some embodiments, the imaging module 101 may include an ultrasound imaging transducer 105 that transmits the ultrasound signals into the human body and receives the reflected signal from the tissue structures. In some embodiments, the imaging module 101 may further include position sensors 106 that are attached to the imaging transducer 105 to acquire the position of the imaging transducer 105 in 3D space and feed the position information to the imaging tracking subsystem 104. In some embodiments, the imaging transducer 105 may be linear, curved linear, phased, annular, or other types of imaging arrays that acquire an imaging plane inside a human body. In some embodiments, the imaging transducer 105 may be a two-dimensional array that acquires 3D ultrasound images inside a human body.
In some embodiments, the 3D position system determines the position of the ultrasound treatment transducer 108 and the relationship of the positions between the imaging transducer 105 and ultrasound treatment transducer 108. In some embodiments, an imaging ultrasound transducer 105 may be included near the therapy module 102, such that images may be acquired of the region of the anatomical structure being targeted, tracked, and treated as will be described below.
In some embodiments, the imaging module may acquire an ultrasound image. For example the imaging module may use echoes of ultrasound pulses to delineate objects or areas of different density in the body. A frequency range used may be between 0.5 to 18 megahertz or up to 50 or 100 megahertz. Alternatively, x-ray, computed tomography, magnetic resonance, or any other type of imaging modality, optical or otherwise, may be used. In some embodiments, the imaging of an anatomical structure may be acquired in a B-mode image, Harmonic image, a color Doppler image, a color power Doppler image, a directional color power Doppler mode image, any other type of image, or any combination of two or more of the foregoing. For example, in a B-mode image and/or Harmonic image, the system may image a two-dimensional cross-section of the tissue. Alternatively or additionally, the system may utilize color Doppler imaging, an imaging technique that combines anatomical information derived using ultrasonic pulse-echo techniques with velocity information derived using ultrasonic Doppler techniques to generate color-coded maps of tissue velocity superimposed on grey-scale images of tissue anatomy. Further, color power Doppler imaging has increased intensity and the added benefit of depicting flow in small vessels.
In some embodiments, the imaging module 101 may function to identify a position of a region of an anatomical structure, such that the therapy module 102 may deliver therapy in a substantially continuous manner to the target tissue. The imaging module 101 may rapidly identify the position of the target tissue such that the therapy module 102 may then rapidly deliver therapy to the target tissue. In an interleaving pattern, the position may be identified, followed by therapy delivery, followed by position identification, and so on. This interleaving pattern of the imaging module and therapy module may occur in rapid, repetitive succession such that therapy is delivered substantially continuously. The rapid, repetitive succession is required, such that the target tissue may be tracked substantially continuously and the therapy may be delivered substantially continuously.
In some embodiments, the imaging module 101 may function rapidly, such that a dose of therapy may be delivered substantially continuously to the target tissue without significant delay between identifying a position of the target tissue and delivering therapy to the target tissue or between subsequent doses of therapy to the target tissue. For example, the imaging module 101 may identify one or more locations and/or features of the region of the anatomical structure in less than 10 seconds, 5 seconds, 3 seconds, 2 seconds, or 1 second. Alternatively, the imaging module may identify one or more locations and/or features of the region of the anatomical structure in less than 1000 milliseconds, 750 milliseconds, 500 milliseconds, 250 milliseconds, 100 milliseconds, 75 milliseconds, 50 milliseconds, 25 milliseconds, 10 milliseconds, 5 milliseconds, or 1 millisecond. In some embodiments, the imaging module may use a frame rate of greater than or equal to 20 Hz. Alternatively, the imaging module may use a frame rate of less than 20 Hz.
Returning to
In some embodiments, the tracking capabilities of the tracker and detector may be combined into one algorithm, negating the need for a separate tracker and detector. In some embodiments, results from the tracker and detector may be compared to templates, which identify a previous shape, location, and/or feature of the region of the anatomical structure. For example, the tracker may be a short-term detector in that the results are compared to several previous image (In-p, In-p-1, - - - In-3, In-2, In-1) and use weighted function to obtain the final position. In some embodiments, the tracker will first look for change near the previous location (i.e. previous image (In-1)) rather than looking throughout the entire image. Further for example, the detector may be a long-term detector in that the results are compared to more than one template (i.e. a template pool) from any number of previous images. In some embodiments, the long-term template management samples breathing cycles. In general, the combination of the complimentary tracker and detector will enable the system to compensate automatically, without user intervention, if the target becomes lost or unfocused. Alternatively, any quantity and/or type of trackers and/or detectors may be used. In some embodiments, the system may include additional trackers and/or detectors such that the additional trackers and/or detectors complement the existing trackers and detectors for tracking a region of an anatomical structure. In some embodiments, the multiple complementary trackers and/or detectors may lead to an increased computation time and/or memory requirements, however the robustness of the system will also improve. In some embodiments, the system 100 further includes an integrator. The integrator is an algorithm configured to compare and/or integrate the results from tracker and detector of the image tracking subsystem of the imaging module 101 and direct the therapy module 102 to deliver the therapy to the target tissue.
The tracker and detector are algorithms for determining a location and/or feature of a region of an anatomical structure. In some embodiments, as shown in
In some embodiments, as shown in
In some embodiments, a first feature histogram indicating a first location or feature of a region of an anatomical structure may be compared to second feature histogram indicating a second location or feature of the region of the anatomical structure. In some embodiments, the first or second feature histogram may include a template from a previous image. The two histograms may be compared using equation (1) below, where H1ij is the first feature histogram, H2ij is the second feature histogram, N is the total number of bins in the x-direction of the 2D feature histogram, M is the total number of bins in the y-direction of the 2D feature histogram, and D is the distance between the two histograms between 0 and 1. When D=0, the two histograms are identical. Conversely, when D=1, the two histograms are the most different.
In some embodiments, alternative algorithms may be employed, such as sum squared difference, sum absolute difference, or normalized cross correlation (NCC). For example, in NCC, a position of the region of the anatomical structure is determined by a pixel-wise comparison of the current image with the template containing a previous position of the region of the anatomical structure. The search region in the template is shifted in discrete steps in the N and M directions, and then the comparison is calculated (i.e. subtracting the mean and dividing by the standard deviation at every step) over the template search area for each position. The position of the maximum NCC values indicates the position of the region of the anatomical structure in the current image. Alternatively, any other threshold NCC value (i.e. minimum) may be used.
In this example, the tracking boxes are tracking a location or feature of a region of an anatomical structure in two images, at opposite ends of a breathing cycle, using a feature histogram algorithm, as described above. For example, a beginning of a breathing cycle is shown in
In some embodiments, the tracking performed by the first and second tracking boxes may occur with an accuracy of root-mean-square (RMS) error of less than or equal to 2 mm. Alternatively, the RMS error may be more than 2 mm, but still within a suitable accuracy. In some embodiments where two tracking boxes are used, if both the tracking boxes 302, 303 are lost, the tracking boxes 302, 303 may recover at the same time and maintain the same relative position with error within less than or equal to 40 pixels. Alternatively, the error may be within more than 40 pixels. Further, in some embodiments, if the region of the anatomical structure moves outside of the image, the tracker and detector will cease to track the region of the anatomical structure.
In some embodiments, as shown in
As shown in
As shown in
In some embodiments, the feature histogram of the current image is compared to all templates in the template pool. Alternatively, the feature histogram of the current image may be compared to a subset of the template pool. In some embodiments, all templates search in their own search regions and the region of the anatomical structure is at the position, which gives the maximum (i.e. NCC value) or minimum value (i.e. sum squared difference value) in all search regions of the templates.
In some embodiments, as shown in
In some embodiments, as shown in
In some embodiments, where the integrator integrated the results from the tracker and detector, as described above with respect to
In some embodiments, the ultrasound transducer of the therapy module may be moved, repositioned, or otherwise relocated by a motion control mechanism. Alternatively, the ultrasound transducer of the therapy module may be directed and moved to guide therapeutic energy to the target tissue, for example by an applicator 1060. In some embodiments, the ultrasound transducer of the therapy module may be moved by a three-dimensional electronic beam steering control mechanism to guide therapeutic energy to the target tissue. Alternatively, the ultrasound transducer of the therapy module may be moved by a mechanical control mechanism to guide therapeutic energy to the target tissue.
In some embodiments, as shown in
As shown in
As shown in
As shown in
As shown in
As shown in
As shown in
In some embodiments, the method of
In some embodiments, the method of
In some embodiments, the method of
In some embodiments, the method of
In some embodiments, the method of
As described herein, a method for treatment includes: acquiring with an imaging module an image of a body portion of a patient; identifying a region of an anatomical structure that has a relationship to a target tissue in the image; tracking a location and/or a feature of the region of the anatomical structure in the image; transforming a target position of the target tissue from an imaging space associated with the imaging module to a treatment space associated with a therapy module through one or more position sensors and a transmitter; and delivering a therapy with the therapy module to the target tissue while tracking the region of the anatomical structure. In some embodiments, the act of transforming is performed to bring a target position of the target tissue (e.g., renal artery) in the imaging space (e.g., ultrasound imaging coordinate) to a transformed target position in the treatment space (e.g., therapeutic array coordinate). Various techniques may be employed to achieve such objective. For example, in some cases, a real-time electromagnetic tracking system with sub-millimeter and sub-degree accuracy may be used. The magnetic field sensor may be attached on the handle of the imaging transducer, and a magnetic field transmitter may be attached to the base of therapeutic treatment module. The magnetic field transmitter generates a magnetic field. When the magnetic sensor is placed inside controlled, varying magnetic fields generated from the transmitter, voltage are induced in the sensor coils. These induced voltages can be used by the measurement system to calculate the position and the orientation of the magnetic field sensor in 3D space. In such cases, after the renal artery target position is detected by ultrasound imaging (in image coordinate), the transformation of the position may be performed as follows: 1) the treatment position and orientation of a target in the image coordinate are linked with the magnetic field sensor position and orientation based on mechanical design and calibration (in magnetic sensor coordinate); 2) the target position and orientation in the magnetic sensor coordinate are then transformed into the treatment module coordinate by the detection of the sensor position and orientation in the magnetic field generated by the magnetic field transmitter, and 3) the target position and orientation in the treatment module coordinate are further transformed into the coordinate of the therapeutic array. In some cases, the third transformation above is not needed if the coordinate frame of the therapeutic array is aligned with the treatment module coordinate frame. Therefore, knowing the position and orientation of the imaged target relative to the coordinate frame of the therapeutic array through the above transformations, the therapeutic system can adjust the mechanical movement of the therapeutic array and/or the phases of the array elements to deliver the ultrasound energy at the imaged treatment target.
In other embodiments, non-magnetic position measurement system may be used. This has the advantage of eliminating the possibilities of wrong targeting when a metal object gets close to the magnetic sensor and the transmitter. For example, in other embodiments, optical position measurement system may be used that measures the 3D positions of either active or passive markers affixed to application-specific tools. In one implementation, three different optical tool plates with at least three optical markers on each plate may be provided. One plate with optical markers is attached with the handle of the imaging transducer. The other two plates are attached on the left and right sides of the therapeutic treatment module separately. An optical position sensor system may be attached to the base of therapeutic treatment module. The optical position sensor system emits infrared (IR) light from its illuminators, similar to the flash on a conventional camera. The emitted IR light reflects back to the Position Sensor off markers (which may be spherical or semi-spherical) on the passive tool plates. The optical position sensor system then measures the positions of the markers and calculates the positions and orientations of the tool plates. The relationship of both positions and orientations between the tool plate attached to the imaging transducer (e.g., the handle) and the treatment module can be determined by the position sensor system at a rate of 20 Hz in real-time. To further optimize the detection accuracy of the positions and orientations between the imaging transducer and treatment module, the two plates which are attached along the left and right side of the treatment module are orientated to the optimized angles for treating the right and left renal denervation separately. In such cases, after the renal artery target position is detected by ultrasound imaging (in image coordinate), the transformation of the positions and orientations of the treatment target from the imaging coordinate to the therapy coordinate may be performed as follows: 1) the target position and orientation in the image coordinate are linked with the optical plate position (of the imaging transducer) based on mechanical design and calibration (to obtain treatment position and orientation in imaging tool plate coordinate); 2) the target position and orientation in the imaging tool plate coordinate are further transformed into optical position sensor coordinate frame; 3) the target position and orientation in the position sensor coordinate frame are then transformed into either left or right tool plate coordinate frame attached on the treatment module depending on the treatment of right or left side renal nerves; 4) the target position and orientation in the left/right treatment tool plate coordinate frame are further transformed to the therapeutic array coordinate frame based on mechanical design dimension and calibrations. Thus, the therapeutic system may control the therapeutic array to deliver the ultrasound energy to the treatment target through the above transformations by adjusting the mechanical movement of the therapeutic array and/or electronic phasing steering (e.g., in depth direction, and/or other direction(s)).
The systems and methods of the preferred embodiment and variations thereof can be embodied and/or implemented at least in part as a machine configured to receive a computer-readable medium storing computer-readable instructions. The instructions are preferably executed by computer-executable components preferably integrated with the imaging module and/or the therapy module. The computer-readable medium can be stored on any suitable computer-readable media such as RAMs, ROMs, flash memory, EEPROMs, optical devices (e.g., CD or DVD), hard drives, floppy drives, or any suitable device. The computer-executable component is preferably a general or application-specific processor, for example Versatile Data Acquisition System (VDAS), but any suitable dedicated hardware or hardware/firmware combination can alternatively or additionally execute the instructions.
In other embodiments, instead of or in addition to using histogram(s), a feature matching technique such as Normalized Cross Correlation method, Sum Square Difference method, Sum Absolute Difference method, etc., may be used.
The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. Other embodiments may be utilized and derived therefrom, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is in fact disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
This application claims priority to and the benefit of U.S. Provisional Patent Application No. 62/075,487, filed on Nov. 5, 2014, the entire disclosure of the above application is expressly incorporated by reference herein. This application is related to international PCT patent application serial No. PCT/US2014/022141, titled “TRANSDUCERS, SYSTEMS, AND MANUFACTURING TECHNIQUES FOR FOCUSED ULTRASOUND THERAPIES”, filed on Mar. 7, 2014, which is herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
385256 | Eggers | Jun 1888 | A |
3274437 | Mastrup | Sep 1966 | A |
3499437 | Balamuth | May 1970 | A |
3552382 | Mount | Jan 1971 | A |
3599477 | Cohen | Aug 1971 | A |
3847016 | Ziedonis | Nov 1974 | A |
3927662 | Ziedonis | Dec 1975 | A |
3969578 | Mezrich | Jul 1976 | A |
4059098 | Murdock | Nov 1977 | A |
4167180 | Kossoff | Sep 1979 | A |
4197856 | Northrop | Apr 1980 | A |
4206763 | Pendersen | Jun 1980 | A |
4237901 | Taenzer | Dec 1980 | A |
4273127 | Auth et al. | Jun 1981 | A |
4469099 | McEwen | Sep 1984 | A |
4479494 | McEwen | Oct 1984 | A |
4484569 | Driller et al. | Nov 1984 | A |
4545386 | Hetz et al. | Oct 1985 | A |
4601296 | Yerushalmi | Jul 1986 | A |
4605010 | McEwen | Aug 1986 | A |
4688578 | Takano et al. | Aug 1987 | A |
4702732 | Powers et al. | Oct 1987 | A |
4708836 | Gain et al. | Nov 1987 | A |
4748985 | Nagasaki | Jun 1988 | A |
4757820 | Itoh | Jul 1988 | A |
4770175 | McEwen | Sep 1988 | A |
4773865 | Baldwin | Sep 1988 | A |
4773899 | Spears | Sep 1988 | A |
4784148 | Dow et al. | Nov 1988 | A |
4841979 | Dow et al. | Jun 1989 | A |
4850363 | Yanagawa | Jul 1989 | A |
4858613 | Fry et al. | Aug 1989 | A |
4905672 | Schwarze et al. | Mar 1990 | A |
4913155 | Dow et al. | Apr 1990 | A |
4929246 | Sinofsky | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4938216 | Lele | Jul 1990 | A |
4938217 | Lele | Jul 1990 | A |
4957099 | Hassler | Sep 1990 | A |
4957481 | Gatenby | Sep 1990 | A |
5005579 | Wurster et al. | Apr 1991 | A |
RE33590 | Dory | May 1991 | E |
5026387 | Thomas | Jun 1991 | A |
5036855 | Fry et al. | Aug 1991 | A |
5039774 | Shikinami et al. | Aug 1991 | A |
5042486 | Pfeiler et al. | Aug 1991 | A |
5048527 | Okazaki | Sep 1991 | A |
5065742 | Belikan et al. | Nov 1991 | A |
5080101 | Dory | Jan 1992 | A |
5080102 | Dory | Jan 1992 | A |
5093570 | Dorfi | Mar 1992 | A |
5150712 | Dory | Sep 1992 | A |
5170790 | Lacoste et al. | Dec 1992 | A |
5178135 | Uchiyama et al. | Jan 1993 | A |
5178148 | Lacoste et al. | Jan 1993 | A |
5181522 | McEwen | Jan 1993 | A |
5193527 | Schaefer | Mar 1993 | A |
5194291 | D'Aoust et al. | Mar 1993 | A |
5211160 | Talish et al. | May 1993 | A |
5215680 | D'Arrigo | Jun 1993 | A |
5219401 | Cathignol et al. | Jun 1993 | A |
5230334 | Klopotek | Jul 1993 | A |
5230921 | Waltonen et al. | Jul 1993 | A |
5233994 | Shmulewitz | Aug 1993 | A |
5243988 | Sieben et al. | Sep 1993 | A |
5254087 | McEwen | Oct 1993 | A |
5263957 | Davison | Nov 1993 | A |
5290278 | Anderson | Mar 1994 | A |
5311869 | Okazaki | May 1994 | A |
5312431 | McEwen | May 1994 | A |
5352195 | McEwen | Oct 1994 | A |
5364389 | Anderson | Nov 1994 | A |
5383896 | Gershony et al. | Jan 1995 | A |
5391140 | Schaetzle et al. | Feb 1995 | A |
5391197 | Burdette et al. | Feb 1995 | A |
5394875 | Lewis | Mar 1995 | A |
5394877 | Orr et al. | Mar 1995 | A |
5413550 | Castel | May 1995 | A |
5415657 | Taymor-Luria | May 1995 | A |
5439477 | McEwen | Aug 1995 | A |
5445608 | Chen et al. | Aug 1995 | A |
5453576 | Krivitski | Sep 1995 | A |
5454373 | Koger et al. | Oct 1995 | A |
5454831 | McEwen | Oct 1995 | A |
5471988 | Fujio et al. | Dec 1995 | A |
5474071 | Chapelon et al. | Dec 1995 | A |
5479375 | Gualtieri | Dec 1995 | A |
5492126 | Hennige et al. | Feb 1996 | A |
5501655 | Rolt et al. | Mar 1996 | A |
5503152 | Oakley et al. | Apr 1996 | A |
5507744 | Tay et al. | Apr 1996 | A |
5507790 | Weiss | Apr 1996 | A |
5515853 | Smith et al. | May 1996 | A |
5520188 | Hennige et al. | May 1996 | A |
5522878 | Montecalvo et al. | Jun 1996 | A |
5524620 | Rosenschein | Jun 1996 | A |
5526815 | Granz et al. | Jun 1996 | A |
5534232 | Denes et al. | Jul 1996 | A |
5536489 | Lohrmann et al. | Jul 1996 | A |
5553618 | Suzuki et al. | Sep 1996 | A |
5556415 | McEwen et al. | Sep 1996 | A |
5558092 | Unger et al. | Sep 1996 | A |
5573497 | Chapelon | Nov 1996 | A |
5574212 | Madsen | Nov 1996 | A |
5578055 | McEwen | Nov 1996 | A |
5584853 | McEwen | Dec 1996 | A |
5598845 | Chandraratna et al. | Feb 1997 | A |
5601526 | Chapelon et al. | Feb 1997 | A |
5607447 | McEwen et al. | Mar 1997 | A |
5609485 | Bergman et al. | Mar 1997 | A |
5626601 | Gershony et al. | May 1997 | A |
5630837 | Crowley | May 1997 | A |
5638823 | Akay et al. | Jun 1997 | A |
5643179 | Fujimoto | Jul 1997 | A |
5649954 | McEwen | Jul 1997 | A |
5655538 | Lorraine et al. | Aug 1997 | A |
5657760 | Ying et al. | Aug 1997 | A |
5665073 | Bulow et al. | Sep 1997 | A |
5666954 | Chapelon et al. | Sep 1997 | A |
5681339 | McEwen et al. | Oct 1997 | A |
5685307 | Holland et al. | Nov 1997 | A |
5695493 | Nakajima et al. | Dec 1997 | A |
5697897 | Buchholtz et al. | Dec 1997 | A |
D389574 | Emerson et al. | Jan 1998 | S |
5711058 | Frey et al. | Jan 1998 | A |
5716374 | Francese et al. | Feb 1998 | A |
5720286 | Chapelon et al. | Feb 1998 | A |
5720287 | Chapelon et al. | Feb 1998 | A |
5722411 | Suzuki | Mar 1998 | A |
5726066 | Choi | Mar 1998 | A |
5735796 | Granz et al. | Apr 1998 | A |
5738635 | Chapelon et al. | Apr 1998 | A |
5741295 | McEwen | Apr 1998 | A |
5755228 | Wilson et al. | May 1998 | A |
5762066 | Law et al. | Jun 1998 | A |
5769790 | Watkins et al. | Jun 1998 | A |
5788636 | Curley | Aug 1998 | A |
5807285 | Vaitekunas | Sep 1998 | A |
5810007 | Holupka et al. | Sep 1998 | A |
5810810 | Tay et al. | Sep 1998 | A |
5817021 | Reichenberger | Oct 1998 | A |
5823962 | Schaetzle et al. | Oct 1998 | A |
5824015 | Sawyer | Oct 1998 | A |
5824277 | Campos | Oct 1998 | A |
5827204 | Grandia et al. | Oct 1998 | A |
5827268 | Laufer | Oct 1998 | A |
5833647 | Edwards | Nov 1998 | A |
5840028 | Chubachi et al. | Nov 1998 | A |
5846517 | Unger | Dec 1998 | A |
5852860 | Lorraine et al. | Dec 1998 | A |
5853752 | Unger et al. | Dec 1998 | A |
5855589 | McEwen et al. | Jan 1999 | A |
5873828 | Fujio et al. | Feb 1999 | A |
5873845 | Cline et al. | Feb 1999 | A |
5879314 | Peterson et al. | Mar 1999 | A |
5882302 | Driscoll, Jr. et al. | Mar 1999 | A |
5882328 | Levy et al. | Mar 1999 | A |
5895356 | Andrus et al. | Apr 1999 | A |
5904659 | Duarte et al. | May 1999 | A |
5906580 | Kline-Schoder et al. | May 1999 | A |
5911735 | McEwen | Jun 1999 | A |
5919139 | Lin | Jul 1999 | A |
5921994 | Andreas et al. | Jul 1999 | A |
5922945 | Allmaras et al. | Jul 1999 | A |
5931786 | Whitmore, III et al. | Aug 1999 | A |
5931853 | McEwen | Aug 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5935146 | McEwen | Aug 1999 | A |
5935339 | Henderson et al. | Aug 1999 | A |
5938600 | Van Vaals et al. | Aug 1999 | A |
5951476 | Beach | Sep 1999 | A |
5957849 | Munro | Sep 1999 | A |
5964782 | Lafontaine et al. | Oct 1999 | A |
5976092 | Chinn | Nov 1999 | A |
5979453 | Savage et al. | Nov 1999 | A |
5993389 | Driscoll, Jr. et al. | Nov 1999 | A |
5997481 | Adams et al. | Dec 1999 | A |
6007499 | Martin et al. | Dec 1999 | A |
6014473 | Hossack et al. | Jan 2000 | A |
6033506 | Klett | Mar 2000 | A |
6036650 | Wu et al. | Mar 2000 | A |
6037032 | Klett et al. | Mar 2000 | A |
6039694 | Larson et al. | Mar 2000 | A |
6050943 | Slayton et al. | Apr 2000 | A |
6067371 | Gouge et al. | May 2000 | A |
6068596 | Weth et al. | May 2000 | A |
6071239 | Cribbs et al. | Jun 2000 | A |
6071277 | Farley et al. | Jun 2000 | A |
6078831 | Belef et al. | Jun 2000 | A |
6083159 | Driscoll, Jr. et al. | Jul 2000 | A |
6087761 | Lorraine et al. | Jul 2000 | A |
6102860 | Mooney | Aug 2000 | A |
6106463 | Wilk | Aug 2000 | A |
6120453 | Sharp | Sep 2000 | A |
6128522 | Acker et al. | Oct 2000 | A |
6179831 | Bliweis | Jan 2001 | B1 |
6182341 | Talbot et al. | Feb 2001 | B1 |
6200539 | Sherman et al. | Mar 2001 | B1 |
6206843 | Iger et al. | Mar 2001 | B1 |
6213939 | McEwen | Apr 2001 | B1 |
6217530 | Martin et al. | Apr 2001 | B1 |
6221015 | Yock | Apr 2001 | B1 |
6231507 | Zikorus et al. | May 2001 | B1 |
6233477 | Chia et al. | May 2001 | B1 |
6246156 | Takeuchi et al. | Jun 2001 | B1 |
6254601 | Burbank et al. | Jul 2001 | B1 |
6259945 | Epstein et al. | Jul 2001 | B1 |
6263551 | Lorraine et al. | Jul 2001 | B1 |
6267734 | Ishibashi et al. | Jul 2001 | B1 |
6270458 | Barnea | Aug 2001 | B1 |
6277077 | Brisken et al. | Aug 2001 | B1 |
6315441 | King | Nov 2001 | B2 |
6315724 | Berman | Nov 2001 | B1 |
6332089 | Acker et al. | Dec 2001 | B1 |
6361496 | Zikorus et al. | Mar 2002 | B1 |
6361548 | McEwen | Mar 2002 | B1 |
6399149 | Klett et al. | Jun 2002 | B1 |
6406759 | Roth | Jun 2002 | B1 |
6409720 | Hissong et al. | Jun 2002 | B1 |
6419669 | Frazier et al. | Jul 2002 | B1 |
6425867 | Vaezy et al. | Jul 2002 | B1 |
6425876 | Frangi et al. | Jul 2002 | B1 |
6432067 | Martin et al. | Aug 2002 | B1 |
6443894 | Sumanaweera et al. | Sep 2002 | B1 |
6453526 | Lorraine et al. | Sep 2002 | B2 |
6488639 | Ribault et al. | Dec 2002 | B1 |
6491672 | Slepian et al. | Dec 2002 | B2 |
6494848 | Sommercorn et al. | Dec 2002 | B1 |
6500133 | Martin et al. | Dec 2002 | B2 |
6506171 | Vitek et al. | Jan 2003 | B1 |
6514221 | Hynynen et al. | Feb 2003 | B2 |
6520915 | Lin et al. | Feb 2003 | B1 |
6522926 | Kieval et al. | Feb 2003 | B1 |
6548047 | Unger | Apr 2003 | B1 |
6551576 | Unger et al. | Apr 2003 | B1 |
6559644 | Froundlich et al. | May 2003 | B2 |
6562037 | Paton et al. | May 2003 | B2 |
6565557 | Sporri et al. | May 2003 | B1 |
6576168 | Hardcastle et al. | Jun 2003 | B2 |
6584360 | Francischelli et al. | Jun 2003 | B2 |
6593574 | Thomas | Jul 2003 | B2 |
6595934 | Hissong et al. | Jul 2003 | B1 |
6599256 | Acker et al. | Jul 2003 | B1 |
6599288 | Maguire | Jul 2003 | B2 |
6602251 | Burbank et al. | Aug 2003 | B2 |
6612988 | Maor et al. | Sep 2003 | B2 |
6616624 | Kieval | Sep 2003 | B1 |
6626855 | Weng et al. | Sep 2003 | B1 |
6633658 | Dabney et al. | Oct 2003 | B1 |
6652461 | Levkovitz | Nov 2003 | B1 |
6656131 | Alster et al. | Dec 2003 | B2 |
6656136 | Weng et al. | Dec 2003 | B1 |
6676601 | Lacoste et al. | Jan 2004 | B1 |
6682483 | Abend et al. | Jan 2004 | B1 |
6685639 | Wang et al. | Feb 2004 | B1 |
6706892 | Ezrin et al. | Mar 2004 | B1 |
6709392 | Salgo et al. | Mar 2004 | B1 |
6709407 | Fatemi | Mar 2004 | B2 |
6716184 | Vaezy et al. | Apr 2004 | B2 |
6719694 | Weng et al. | Apr 2004 | B2 |
6719699 | Smith | Apr 2004 | B2 |
6726627 | Lizzi et al. | Apr 2004 | B1 |
6728566 | Subramanyan et al. | Apr 2004 | B1 |
6735461 | Vitek et al. | May 2004 | B2 |
6755789 | Stringer et al. | Jun 2004 | B2 |
6764488 | Burbank et al. | Jul 2004 | B1 |
6846291 | Smith et al. | Jan 2005 | B2 |
6875176 | Mourad et al. | Apr 2005 | B2 |
6875420 | Quay | Apr 2005 | B1 |
6905498 | Hooven | Jun 2005 | B2 |
6932771 | Whitmore et al. | Aug 2005 | B2 |
6955648 | Mozayeni et al. | Oct 2005 | B2 |
6978174 | Gelfand et al. | Dec 2005 | B2 |
7022077 | Mourad et al. | Apr 2006 | B2 |
7052463 | Peszynski et al. | May 2006 | B2 |
7063666 | Weng et al. | Jun 2006 | B2 |
7128711 | Medan et al. | Oct 2006 | B2 |
7149564 | Vining et al. | Dec 2006 | B2 |
7162303 | Levin et al. | Jan 2007 | B2 |
7211060 | Talish et al. | May 2007 | B1 |
7260250 | Summers et al. | Aug 2007 | B2 |
7285093 | Anisimov et al. | Oct 2007 | B2 |
7374538 | Nightingale et al. | May 2008 | B2 |
7445599 | Kelly et al. | Nov 2008 | B2 |
7470241 | Weng et al. | Dec 2008 | B2 |
7499748 | Moffitt et al. | Mar 2009 | B2 |
7510536 | Foley et al. | Mar 2009 | B2 |
7530958 | Slayton et al. | May 2009 | B2 |
7534209 | Abend | May 2009 | B2 |
7553284 | Vaitekunas | Jun 2009 | B2 |
7617005 | Demarais et al. | Nov 2009 | B2 |
7620451 | Demarais et al. | Nov 2009 | B2 |
7628764 | Duarte et al. | Dec 2009 | B2 |
7684865 | Aldrich et al. | Mar 2010 | B2 |
7697972 | Verard et al. | Apr 2010 | B2 |
7698947 | Sarr | Apr 2010 | B2 |
7725184 | Cazares | May 2010 | B2 |
7766833 | Lee | Aug 2010 | B2 |
7783358 | Aldrich et al. | Aug 2010 | B2 |
8295912 | Gertner | Oct 2012 | B2 |
8347891 | Demarais et al. | Jan 2013 | B2 |
8383671 | Consigny | Feb 2013 | B1 |
8556834 | Gertner | Oct 2013 | B2 |
8715209 | Gertner | May 2014 | B2 |
9234878 | Lavrentyev | Jan 2016 | B2 |
20010014775 | Koger et al. | Aug 2001 | A1 |
20010014805 | Burbank et al. | Aug 2001 | A1 |
20010032382 | Lorraine et al. | Oct 2001 | A1 |
20010041910 | McEwen | Nov 2001 | A1 |
20010044636 | Pedros et al. | Nov 2001 | A1 |
20020055736 | Horn et al. | May 2002 | A1 |
20020072672 | Roundhill et al. | Jun 2002 | A1 |
20020095164 | Andreas et al. | Jul 2002 | A1 |
20020143275 | Sarvazyan | Oct 2002 | A1 |
20020193831 | Smith, III | Dec 2002 | A1 |
20030009194 | Saker et al. | Jan 2003 | A1 |
20030010124 | Bates | Jan 2003 | A1 |
20030018255 | Martin et al. | Jan 2003 | A1 |
20030036771 | McEwen | Feb 2003 | A1 |
20030050665 | Ginn | Mar 2003 | A1 |
20030060737 | Brisken | Mar 2003 | A1 |
20030069569 | Burdette et al. | Apr 2003 | A1 |
20030114756 | Li | Jun 2003 | A1 |
20030120204 | Unger et al. | Jun 2003 | A1 |
20030149366 | Stringer et al. | Aug 2003 | A1 |
20030153849 | Huckle et al. | Aug 2003 | A1 |
20030187371 | Vortman et al. | Oct 2003 | A1 |
20030195420 | Mendlein et al. | Oct 2003 | A1 |
20030208101 | Cecchi | Nov 2003 | A1 |
20030216792 | Levin et al. | Nov 2003 | A1 |
20030225331 | Diederich et al. | Dec 2003 | A1 |
20040002654 | Davidson et al. | Jan 2004 | A1 |
20040030227 | Littrup et al. | Feb 2004 | A1 |
20040030268 | Weng et al. | Feb 2004 | A1 |
20040030269 | Horn et al. | Feb 2004 | A1 |
20040039280 | Wu et al. | Feb 2004 | A1 |
20040049105 | Crutchfield et al. | Mar 2004 | A1 |
20040054287 | Stephens | Mar 2004 | A1 |
20040054289 | Eberle et al. | Mar 2004 | A1 |
20040056200 | Rothenfusser | Mar 2004 | A1 |
20040057492 | Vona | Mar 2004 | A1 |
20040071664 | McHale et al. | Apr 2004 | A1 |
20040078034 | Acker et al. | Apr 2004 | A1 |
20040078219 | Kaylor et al. | Apr 2004 | A1 |
20040082978 | Harrison et al. | Apr 2004 | A1 |
20040089811 | Lewis | May 2004 | A1 |
20040097805 | Verard et al. | May 2004 | A1 |
20040097840 | Holmer | May 2004 | A1 |
20040106880 | Weng et al. | Jun 2004 | A1 |
20040113524 | Baumgartner et al. | Jun 2004 | A1 |
20040122493 | Ishibashi et al. | Jun 2004 | A1 |
20040127798 | Dala-Krishna et al. | Jul 2004 | A1 |
20040153126 | Okai | Aug 2004 | A1 |
20040158154 | Hanafy et al. | Aug 2004 | A1 |
20040210214 | Knowlton | Oct 2004 | A1 |
20040220167 | Samly | Nov 2004 | A1 |
20040234453 | Smith | Nov 2004 | A1 |
20040254620 | Lacoste et al. | Dec 2004 | A1 |
20040267252 | Washington et al. | Dec 2004 | A1 |
20050038339 | Chauhan et al. | Feb 2005 | A1 |
20050038340 | Vaezy et al. | Feb 2005 | A1 |
20050043625 | Oliver et al. | Feb 2005 | A1 |
20050046311 | Baumgartner et al. | Mar 2005 | A1 |
20050054955 | Lidgren | Mar 2005 | A1 |
20050065436 | Ho et al. | Mar 2005 | A1 |
20050070790 | Niwa et al. | Mar 2005 | A1 |
20050085793 | Glossop | Apr 2005 | A1 |
20050090104 | Yang et al. | Apr 2005 | A1 |
20050092091 | Greelish | May 2005 | A1 |
20050096538 | Chomas et al. | May 2005 | A1 |
20050096542 | Weng et al. | May 2005 | A1 |
20050119704 | Peters et al. | Jun 2005 | A1 |
20050149126 | Libbus | Jul 2005 | A1 |
20050154299 | Hoctor et al. | Jul 2005 | A1 |
20050165298 | Larson et al. | Jul 2005 | A1 |
20050182297 | Gravenstein et al. | Aug 2005 | A1 |
20050182319 | Glossop | Aug 2005 | A1 |
20050192638 | Gelfand et al. | Sep 2005 | A1 |
20050240102 | Rachlin et al. | Oct 2005 | A1 |
20050240103 | Byrd et al. | Oct 2005 | A1 |
20050240126 | Foley et al. | Oct 2005 | A1 |
20050240127 | Seip et al. | Oct 2005 | A1 |
20050240170 | Zhang et al. | Oct 2005 | A1 |
20050240241 | Yun et al. | Oct 2005 | A1 |
20050261672 | Deem et al. | Nov 2005 | A1 |
20050277853 | Mast et al. | Dec 2005 | A1 |
20050288730 | Deem et al. | Dec 2005 | A1 |
20060004417 | Rossing | Jan 2006 | A1 |
20060025756 | Francischelli et al. | Feb 2006 | A1 |
20060052701 | Carter et al. | Mar 2006 | A1 |
20060058678 | Vitek et al. | Mar 2006 | A1 |
20060058707 | Barthe et al. | Mar 2006 | A1 |
20060082771 | Doerrmann et al. | Apr 2006 | A1 |
20060084966 | Maguire et al. | Apr 2006 | A1 |
20060122514 | Byrd et al. | Jun 2006 | A1 |
20060184069 | Vaitekunas | Aug 2006 | A1 |
20060235300 | Weng et al. | Oct 2006 | A1 |
20060235303 | Vaezy et al. | Oct 2006 | A1 |
20060287681 | Yonce | Dec 2006 | A1 |
20060293712 | Kieval et al. | Dec 2006 | A1 |
20070004984 | Crum et al. | Jan 2007 | A1 |
20070016113 | Buchholtz | Jan 2007 | A1 |
20070016274 | Boveja et al. | Jan 2007 | A1 |
20070038115 | Quigley et al. | Feb 2007 | A1 |
20070055155 | Owen et al. | Mar 2007 | A1 |
20070055181 | Deem et al. | Mar 2007 | A1 |
20070066957 | Demarais et al. | Mar 2007 | A1 |
20070106339 | Errico et al. | May 2007 | A1 |
20070112327 | Yun et al. | May 2007 | A1 |
20070129720 | Demarais et al. | Jun 2007 | A1 |
20070129761 | Demarais et al. | Jun 2007 | A1 |
20070135875 | Demarais et al. | Jun 2007 | A1 |
20070142879 | Greenberg et al. | Jun 2007 | A1 |
20070149880 | Willis | Jun 2007 | A1 |
20070167806 | Wood et al. | Jul 2007 | A1 |
20070179379 | Weng et al. | Aug 2007 | A1 |
20070203527 | Ben-David et al. | Aug 2007 | A1 |
20070213616 | Anderson et al. | Sep 2007 | A1 |
20070233185 | Anderson et al. | Oct 2007 | A1 |
20070239000 | Emery et al. | Oct 2007 | A1 |
20070265687 | Deem et al. | Nov 2007 | A1 |
20070282407 | Demarais et al. | Dec 2007 | A1 |
20080030104 | Prus | Feb 2008 | A1 |
20080033292 | Shafran | Feb 2008 | A1 |
20080033420 | Nields et al. | Feb 2008 | A1 |
20080039746 | Hissong et al. | Feb 2008 | A1 |
20080045864 | Candy et al. | Feb 2008 | A1 |
20080045865 | Kislev | Feb 2008 | A1 |
20080046016 | Ben-David | Feb 2008 | A1 |
20080047325 | Bartlett | Feb 2008 | A1 |
20080051767 | Rossing et al. | Feb 2008 | A1 |
20080058683 | Gifford et al. | Mar 2008 | A1 |
20080194954 | Unger et al. | Aug 2008 | A1 |
20080200806 | Liu et al. | Aug 2008 | A1 |
20080200815 | Van Der Steen et al. | Aug 2008 | A1 |
20080234569 | Tidhar et al. | Sep 2008 | A1 |
20080255498 | Houle | Oct 2008 | A1 |
20080255642 | Zarins et al. | Oct 2008 | A1 |
20080261009 | Kawabata | Oct 2008 | A1 |
20080288017 | Kieval | Nov 2008 | A1 |
20080312561 | Chauhan | Dec 2008 | A1 |
20080312562 | Routh et al. | Dec 2008 | A1 |
20080317204 | Sumanaweera et al. | Dec 2008 | A1 |
20080319375 | Hardy | Dec 2008 | A1 |
20090000382 | Sathish | Jan 2009 | A1 |
20090012098 | Jordan et al. | Jan 2009 | A1 |
20090036948 | Levin et al. | Feb 2009 | A1 |
20090054770 | Daigle | Feb 2009 | A1 |
20090062697 | Zhang et al. | Mar 2009 | A1 |
20090062873 | Wu et al. | Mar 2009 | A1 |
20090076409 | Wu et al. | Mar 2009 | A1 |
20090088623 | Vortman et al. | Apr 2009 | A1 |
20090099627 | Molnar | Apr 2009 | A1 |
20090112095 | Daigle | Apr 2009 | A1 |
20090112133 | Deisseroth et al. | Apr 2009 | A1 |
20090137873 | Mitsuhashi | May 2009 | A1 |
20090149782 | Cohen et al. | Jun 2009 | A1 |
20090163982 | Decharms | Jun 2009 | A1 |
20090221908 | Glossop | Sep 2009 | A1 |
20090221939 | Demarais et al. | Sep 2009 | A1 |
20090247911 | Novak et al. | Oct 2009 | A1 |
20090264755 | Chen et al. | Oct 2009 | A1 |
20090306644 | Mayse et al. | Dec 2009 | A1 |
20090315978 | Wurmlin | Dec 2009 | A1 |
20100010393 | Duffy et al. | Jan 2010 | A1 |
20100022921 | Seip et al. | Jan 2010 | A1 |
20100023088 | Stack et al. | Jan 2010 | A1 |
20100042020 | Ben-Ezra | Feb 2010 | A1 |
20100081971 | Allison | Apr 2010 | A1 |
20100092424 | Sanghvi et al. | Apr 2010 | A1 |
20100125269 | Emmons et al. | May 2010 | A1 |
20100128141 | Jang | May 2010 | A1 |
20100160781 | Carter et al. | Jun 2010 | A1 |
20100174188 | Wang et al. | Jul 2010 | A1 |
20100286522 | Beach | Nov 2010 | A1 |
20110021913 | Weng et al. | Jan 2011 | A1 |
20110028867 | Choo et al. | Feb 2011 | A1 |
20110060255 | Chen | Mar 2011 | A1 |
20110092781 | Gertner | Apr 2011 | A1 |
20110092880 | Gertner | Apr 2011 | A1 |
20110112400 | Emery et al. | May 2011 | A1 |
20110118805 | Wei | May 2011 | A1 |
20110124976 | Sabczynski et al. | May 2011 | A1 |
20110234834 | Sugimoto | Sep 2011 | A1 |
20110251489 | Zhang et al. | Oct 2011 | A1 |
20110257523 | Hastings | Oct 2011 | A1 |
20110257561 | Gertner et al. | Oct 2011 | A1 |
20110260965 | Kim | Oct 2011 | A1 |
20110319765 | Gertner et al. | Dec 2011 | A1 |
20120065492 | Gertner et al. | Mar 2012 | A1 |
20120109018 | Gertner et al. | May 2012 | A1 |
20120123243 | Hastings | May 2012 | A1 |
20130120552 | Yamanaka | May 2013 | A1 |
20130245429 | Zhang | Sep 2013 | A1 |
20140005477 | Gupta | Jan 2014 | A1 |
20140043933 | Belevich | Feb 2014 | A1 |
20140086684 | Sehr | Mar 2014 | A1 |
20140171782 | Bruder | Jun 2014 | A1 |
20140275705 | Virshup | Sep 2014 | A1 |
20140316269 | Zhang | Oct 2014 | A1 |
20140331771 | Baba | Nov 2014 | A1 |
20150005613 | Kim | Jan 2015 | A1 |
20150029819 | Yacoubian | Jan 2015 | A1 |
20150092814 | Wolfgruber | Apr 2015 | A1 |
20150175747 | Liu | Jun 2015 | A1 |
20150231414 | Ein-Gal | Aug 2015 | A1 |
20150253266 | Lu con | Sep 2015 | A1 |
20160109393 | Man Delis | Apr 2016 | A1 |
20160121142 | Zhang | May 2016 | A1 |
20160299108 | Bisle | Oct 2016 | A1 |
20160317122 | dos Santos Mendonca | Nov 2016 | A1 |
20170097280 | Drescher | Apr 2017 | A1 |
20170212066 | Thompson | Jul 2017 | A1 |
Number | Date | Country |
---|---|---|
0225120 | Jun 1987 | EP |
0420758 | Apr 1991 | EP |
0679371 | Nov 1995 | EP |
1265223 | Dec 2002 | EP |
1579889 | Sep 2005 | EP |
1847294 | Oct 2007 | EP |
H05-220152 | Aug 1993 | JP |
2007000218 | Jan 2007 | JP |
WO 9502361 | Jan 1995 | WO |
WO 1997031364 | Aug 1997 | WO |
WO 1999048621 | Sep 1999 | WO |
WO 2001034018 | May 2001 | WO |
WO 2002069805 | Sep 2002 | WO |
WO 2005030295 | Apr 2005 | WO |
WO 2006003606 | Jan 2006 | WO |
WO 2006121447 | Nov 2006 | WO |
WO 2006129099 | Dec 2006 | WO |
WO 2008144274 | Nov 2008 | WO |
WO 2009003138 | Dec 2008 | WO |
WO 2009018351 | Feb 2009 | WO |
WO 2009018394 | Feb 2009 | WO |
WO 2009081339 | Jul 2009 | WO |
WO 2011053757 | May 2011 | WO |
WO 2011053772 | May 2011 | WO |
Number | Date | Country | |
---|---|---|---|
20160121142 A1 | May 2016 | US |
Number | Date | Country | |
---|---|---|---|
62075487 | Nov 2014 | US |